New BD Veritor Plus for In-Office Detection of Flu, RSV, Group A Strep

BD has unveiled a new portable device for rapid detection of influenza A and B, respiratory syncytial virus (RSV), and group A strep. The immunoassay device can allow physicians to diagnose patients and decide on a therapy regimen all within one office visit. This can help get the patient started taking pills earlier and so lead to better overall outcomes.

The device is an upgrade to the original BD Veritor, and promises improved quality control of the results, as well as data keeping that can help trace patients to their tests. It can be connected to the cloud via BD’s own platform so that results are automatically moved to the clinic’s electronic medical record or laboratory info system.

“As we are on the cusp of the flu season, it is critical that providers have the diagnostic tools they need to assist them in quickly and accurately identifying infectious diseases, like flu, RSV and strep and in assigning treatment protocols,” said Dave Hickey, president of Diagnostic Systems at BD, in a statement. “The BD Veritor Plus System’s ability to provide reliable test results and wirelessly transfer them to health records could ultimately lead to better outcomes through rapid detection and simplified workflow.”